NCT06554600
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hanzhou, Zhejiang, China
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT06554626
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT06550102
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +11 more
- Locations
-
- University Children's Hospital Zurich Zurich, Canton of Zurich, Switzerland
NCT05873322
- Conditions
- Drug-Induced Diabetes Mellitus, Glucose Intolerance, Glucose Metabolism Disorders, +16 more
- Locations
-
- Aarhus University Hospital Aarhus N, Denmark
NCT06161896
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Zealand University Hospital, Department of Hematology Roskilde, Region Sjælland, Denmark
Recruiting
DAratumumab and REvlimid REfractory MM
NCT06541860
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Irccs San Matteo Pavia Pavia, PV, Italy
NCT06392581
- Conditions
- Acute Lymphoblastic Leukemia, Bacterial Infections and Mycoses, Hematologic Diseases, +13 more
- Locations
-
- ASST degli Spedali Civili di Brescia Brescia, Italy
NCT06522555
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China
NCT06534762
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
Recruiting
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
NCT06468267
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China